NLR (Neutrophil:Lymphocyte

• NLR is a powerful predictor of outcomes in cardiovascular disease, cancer, infections, and autoimmune conditions
• Elevated NLR indicates heightened inflammatory state and is associated with increased mortality risk
• It's particularly useful for assessing disease severity and prognosis in critical illness, COVID-19, and cancer patients
• Lower values suggest better immune balance and reduced systemic inflammation

Neutrophils / Lymphocytes

• The Neutrophil-to-Lymphocyte Ratio (NLR) is a simple, cost-effective marker of systemic inflammation and immune function
• It reflects the balance between innate immunity (neutrophils) and adaptive immunity (lymphocytes)

• High NLR: Often no direct symptoms, but associated conditions may cause fatigue, recurrent infections, poor wound healing, chronic pain, and general malaise
• May indicate underlying inflammatory conditions or immune dysfunction

• High NLR: Acute infections, chronic inflammation, stress (physical or psychological), obesity, smoking, cardiovascular disease, cancer, autoimmune disorders, corticosteroid use, and severe illness.
• Low NLR: Generally favorable, but very low values may indicate immunocompromised states or bone marrow disorders.